Sign in

CIK 0000925741

  • Non-accelerated filer
  • Smaller reporting company

BioCardia, Inc.

Sign in to watch
Ticker
BCDA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
232753988
Phone
+1 650-226-0123
Business address
320 SOQUEL WAY, SUNNYVALE, CA, 94085
Former names
Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
  1. 4 Exercise or conversion Director acquired 567 shares (option exercise)
  2. 4 Exercise or conversion Director acquired 567 shares (option exercise)
  3. 4 Open-market buy President and CEO bought 4,000 shares at $3.67 ($14,676)
  4. 4 Open-market buy President and CEO bought 200 shares at $4.34 ($868)
  5. 4 Open-market buy President and CEO bought 200 shares at $3.99 ($798)
  6. 4 Open-market buy President and CEO bought 5,700 shares at an average $3.47 ($19,771)
  7. 4 Exercise or conversion Director acquired 3,594 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 4,161 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 3,594 shares (option exercise)
  10. 4 Exercise or conversion Director acquired 4,161 shares (option exercise)
  11. 4 Exercise or conversion Director acquired 3,594 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 4,161 shares (option exercise)
  13. 4 Exercise or conversion Director acquired 4,161 shares (option exercise)
  14. 4 Conversion Chief Financial Officer acquired 16,871 shares (conversion)
  15. 4 Conversion Chief Medical Officer acquired 8,435 shares (conversion)
  16. 4 Conversion President and CEO acquired 67,484 shares (conversion)
  17. 4 Conversion Director acquired 16,871 shares (conversion)
  18. 4 Open-market buy Director bought 166,666 shares at $6.00 ($999,996)
  19. 4 Open-market buy President and CEO bought 600 shares at $8.71 ($5,223)
  20. 4 Open-market buy President and CEO bought 700 shares at an average $10.63 ($7,442)

Page 13 of 23 · 442 filings